>peptide 1 (50 aa)
MKGREVEKAFSLILHLKLVSPVPLCRNRIVCAKNAILPRSPPLLNCRPFS*
>peptide 2 (73 aa)
MFIEHINEKFYSKIYKKKEKLQFERKNKRLYLSMVEKSRRHINPRQTSVSFTNINTGSVDSANFFFQHVFRTQ*
>peptide 3 (48 aa)
MLVMEEFRKLLLLSDRALFLVEFELWNCATKLSFRKRVSLVTGRRFRNN
>peptide 4 (37 aa)
MFSEPNNNSSSPELFKLSLNIHCSYSFILFKLILKVH*
>peptide 5 (35 aa)
MRNSIVKYIKRKRNCNLKERIRDFTCPWWKNLEGT*
>CNT0002954
TCTCGGTATTCAGAAAAGTTTCAACAGCAGCTGCATCCGCTAATGACTTATAAGTTGCTTCAAGAGTGCGTATAGCAACAGTAGTGTCCATGTTCATAGA
ACATATAAATGAGAAATTCTATAGTAAAATATATAAAAAGAAAGAGAAATTGCAATTTGAAAGAAAGAATAAGAGACTTTACTTGTCCATGGTGGAAAAA
TCTCGAAGGCACATAAATCCAAGACAAACCTCTGTTTCCTTCACAAACATAAACACCGGTTCTGTAGATTCTGCCAATTTCTTCTTTCAACATGTTTTCA
GAACCCAATAATAATTCCTCCAGTCCAGAGCTATTCAAGCTCAGCCTCAATATTCACTGTAGCTACTCTTTCATACTATTCAAACTAATTTTAAAAGTTC
ACTAACTTGTCACATGCTTCAAATTTCCAAATAGGGAATAACACATTAACACCATTCAAAATCTGCTTTCAAAAATAATCAAAAACAATTTCAATATTAG
GACATACCACCTAATCCCAATACCCGTGCAACATAGAACTCATTGGAAGAAAAACCAATAGTAGAATTCAAAACATAAAATGGAAACTCACTACTAAGAA
AAACCAATACCTGATAGATAATTGCAGGTGTACCAATCTCCAATGAAAACAATAAGTCCCCATATGGGGTATCAAAAGGAATCAGAATGATGGGCCTGTT
GTTTATTATGATGAAACCCCCAAATCCACCAACAACTCTCTGAAGATGAAGGGAAGGGAAGTAGAAAAAGCTTTCAGTTTGATCCTTCACTTGAAACTGG
TAAGTCCAGTTCCACTTTGCAGGAATAGGATAGTTTGTGCCAAGAATGCCATCTTGCCACGAAGTCCTCCTTTGTTGAACTGTAGACCTTTCTCATGAAA
ATTCCATAACTTTTGAGCTCACTGAAAACAAATCTGGTAACCCCTACCCCCCCCATATATAGTAGTACTGGTGCCTATGAAAATTGTGTACTGAAATTAA
ATTGCAAAATCTATAGAAATGTCTAAAATGGTTCAAAAATAAGGCATAAACCTCCGAAACCCCCTACTATACCGAAACCGCAACCTACGCCAAAACCTAA
AAAAGAAAAATTAGCATTCGAGATAGGAATTTGAGATTCCAAGTATGCAGAAATCGTGAAACCCAAACTAGCGTACCAAATCCAATCCTGGTTCCGTTGA
AGGAAATAACCATTTCCTTCTTTCTTTCTTTATTTCTTTCTTTCTTTCTAGCTATATGGAGTTAAAGGAAATCACAAAAGAGCGAGTGCGAATTAATTAA
CTAGTCGAGAGTTAAAGGAACTCACTCCGGAACCCTATTTTCCTTTTTTGCTGAGGACTACAACGACAATGACGACATCATTTTGCGCCAGCTCTCGTTC
CTGAGAACTGTTTGGGTTAGCGATGCCACCGTCGAGTCCATGTTGGTGATGGAAGAGTTCAGGAAGCTTCTGTTGCTCTCTGATAGGGCTCTGTTCTTGG
TCGAATTTGAACTCTGGAATTGCGCCACAAAATTAAGTTTCCGGAAGAGGGTTTCGTTGGTCACGGGGAGAAGATTTAGGAATAAT
| Potential function | Interacting transcript | Gene description | Transcript biotype | lncRNA id | Alignment score (LAST) | Alignment length | Transcript region involved in interaction | Genomic orientation of interacting RNAs |
|---|---|---|---|---|---|---|---|---|
| GLYMA02G41700.1 | Alpha-form rubisco activase; Uncharacterized protein | protein coding | CNT0002954 | 125 | 62 | CDS | Trans | |
| GLYMA04G04695.1 | Uncharacterized protein | protein coding | CNT0002954 | 486 | 225 | CDS | Trans | |
| GLYMA04G14470.3 | Uncharacterized protein | protein coding | CNT0002954 | 428 | 224 | CDS_UTR | Trans | |
| GLYMA04G14470.4 | Uncharacterized protein | protein coding | CNT0002954 | 428 | 224 | CDS_UTR | Trans | |
| GLYMA04G14470.5 | Uncharacterized protein | protein coding | CNT0002954 | 428 | 224 | CDS_UTR | Trans | |
| GLYMA04G14470.6 | Uncharacterized protein | protein coding | CNT0002954 | 428 | 224 | CDS_UTR | Trans | |
| GLYMA04G14470.7 | Uncharacterized protein | protein coding | CNT0002954 | 428 | 224 | CDS_UTR | Trans | |
| GLYMA05G04270.1 | Uncharacterized protein | protein coding | CNT0002954 | 652 | 316 | CDS | Trans | |
| GLYMA06G04775.1 | Uncharacterized protein | protein coding | CNT0002954 | 389 | 224 | CDS | Trans | |
| GLYMA06G46620.1 | Uncharacterized protein | protein coding | CNT0002954 | 379 | 219 | CDS | Trans | |
| GLYMA06G46620.2 | Uncharacterized protein | protein coding | CNT0002954 | 379 | 219 | CDS | Trans | |
| GLYMA15G11570.1 | Uncharacterized protein | protein coding | CNT0002954 | 97 | 128 | CDS | Trans |